Repurposing high-throughput image assays enables biological activity prediction for drug discovery J Simm, G Klambauer, A Arany, M Steijaert, JK Wegner, E Gustin, ... Cell chemical biology 25 (5), 611-618. e3, 2018 | 94 | 2018 |
GRU-ODE-Bayes: Continuous modeling of sporadically-observed time series E De Brouwer, J Simm, A Arany, Y Moreau Advances in Neural Information Processing Systems, 7379-7390, 2019 | 35 | 2019 |
Drug repositioning for treatment of movement disorders: from serendipity to rational discovery strategies B Bolgár, Á Arany, G Temesi, B Balogh, P Antal, P Mátyus Current topics in medicinal chemistry 13 (18), 2337-2363, 2013 | 29 | 2013 |
Macau: Scalable Bayesian factorization with high-dimensional side information using MCMC J Simm, A Arany, P Zakeri, T Haber, JK Wegner, V Chupakhin, ... 2017 IEEE 27th International Workshop on Machine Learning for Signal …, 2017 | 27 | 2017 |
Macau: scalable bayesian multi-relational factorization with side information using MCMC J Simm, A Arany, P Zakeri, T Haber, JK Wegner, V Chupakhin, ... arXiv preprint arXiv:1509.04610, 2015 | 23 | 2015 |
Multi-aspect candidates for repositioning: data fusion methods using heterogeneous information sources A Arany, B Bolgár, B Balogh, P Antal, P Mátyus Current medicinal chemistry 20 (1), 95-107, 2013 | 19 | 2013 |
Pharmacogenetic analysis of high-dose methotrexate treatment in children with osteosarcoma M Hegyi, A Arany, AF Semsei, K Csordas, O Eipel, A Gezsi, N Kutszegi, ... Oncotarget 8 (6), 9388, 2017 | 18 | 2017 |
Gene prioritization using Bayesian matrix factorization with genomic and phenotypic side information P Zakeri, J Simm, A Arany, S ElShal, Y Moreau Bioinformatics 34 (13), i447-i456, 2018 | 15 | 2018 |
Early repositioning through compound set enrichment analysis: a knowledge-recycling strategy G Temesi, B Bolgár, Á Arany, C Szalai, P Antal, P Mátyus Future medicinal chemistry 6 (5), 563-575, 2014 | 11 | 2014 |
Genetic variability of the oxytocine receptor: an in silico study P Marx, A Arany, Z Rónai, P Antal, M Sasvári-Szekely Neuropsychopharmacologia Hungarica: a Magyar Pszichofarmakologiai Egyesulet …, 2011 | 8 | 2011 |
A comprehensive comparison of two MEDLINE annotators for disease and gene linkage: sometimes less is more S ElShal, J Simm, A Arany, P Zakeri, J Davis, Y Moreau International Conference on Bioinformatics and Biomedical Engineering, 765-778, 2016 | 3 | 2016 |
Highly Scalable Tensor Factorization for Prediction of Drug-Protein Interaction Type A Arany, J Simm, P Zakeri, T Haber, JK Wegner, V Chupakhin, ... arXiv preprint arXiv:1512.00315, 2015 | 3 | 2015 |
An interpretable low-complexity machine learning framework for robust exome-based in-silico diagnosis of Crohn’s disease patients D Raimondi, J Simm, A Arany, P Fariselli, I Cleynen, Y Moreau NAR Genomics and Bioinformatics 2 (1), lqaa011, 2020 | 1 | 2020 |
ChemGrapher: Optical Graph Recognition of Chemical Compounds by Deep Learning M Oldenhof, A Arany, Y Moreau, J Simm arXiv preprint arXiv:2002.09914, 2020 | 1 | 2020 |
Graph Informer Networks for Molecules J Simm, A Arany, E De Brouwer, Y Moreau arXiv preprint arXiv:1907.11318, 2019 | 1 | 2019 |
SMURFF: a High-Performance Framework for Matrix Factorization TV Aa, I Chakroun, TJ Ashby, J Simm, A Arany, Y Moreau, TL Van, ... arXiv preprint arXiv:1904.02514, 2019 | 1 | 2019 |
Secure Broker-Mediated Data Analysis and Prediction H Ceulemans, R Wuyts, W Verachtert, J Simm, A Arany, YJL Moreau, ... US Patent App. 15/722,742, 2019 | 1 | 2019 |
Deep Ensemble Tensor Factorization for Longitudinal Patient Trajectories Classification E De Brouwer, J Simm, A Arany, Y Moreau arXiv preprint arXiv:1811.10501, 2018 | 1 | 2018 |
Gene prioritization through Bayesian matrix factorization P Zakeri, J Simm, A Arany, S Elshal, Y Moreau Proceedings of the ISMB/ECCB 2015 Conference, 2015 | 1 | 2015 |
Multilevel Gibbs Sampling for Bayesian Regression J Tavernier, J Simm, A Arany, K Meerbergen, Y Moreau arXiv preprint arXiv:2009.12132, 2020 | | 2020 |